Digital Transformation

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

OptimumBank Holdings leverages its deep expertise in healthcare and multifamily real estate by launching OptimumFunding, a new HUD and FHA lending platform.

Facing financial headwinds, network supplier DAVOLINK is merging with LoadRunner, pivoting to the booming but brutal AI-driven industrial automation market.

Verrica Pharmaceuticals heads to a key investor conference with strong YCANTH sales, a promising pipeline for warts and skin cancer, and high expectations.

AI firm DreamzTech Solutions gains major recognition, validating its AI-first strategy and signaling a new wave of Indian tech leaders on the global stage.

As Northern Virginia home prices jump over 7%, strategic kitchen and bath renovations offer homeowners some of the highest returns on their investment.

With record results and a pivot to oil, the Calgary firm is accelerating its growth targets and challenging the status quo in Canada's prized Duvernay play.

A brief delay in Avidity's stockholder vote signals the final, complex steps before its acquisition by Novartis and the launch of a new spin-off.

A five-year pivot from office buildings to luxury apartments culminates in a blockbuster private buyout, validating a risky strategy and igniting the market.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

After halting all R&D, PCI Biotech proposes dissolution and delisting, marking the end for its novel drug delivery platform and a warning for investors.

A new app aims to reduce the burden on families by centralizing care, medical, and long-term financial plans in one secure platform.

Friction and heat are destroying your mower's engine. A new checklist from Toro shows how a simple annual check-up can prevent costly spring breakdowns.

Madison Capital Group offers a new DST for a luxury Asheville community, tapping a hot market facing a surge in supply and evolving economic crosscurrents.

With its newly approved VIZZ eye drop, LENZ Therapeutics is wooing investors, aiming to capture a slice of the massive, underserved presbyopia market.

Following a series of acquisitions, Southwest Strategies Group rebrands as Bodewell, positioning itself to manage public consent for a new era of US infrastructure.

January data shows a massive jump in corporate financing requests, hinting at a busy year for investment, while the municipal market tells a different story.

A patent-pending tubing anchor catcher is showing early promise, with reports of 100% production gains by tackling stubborn gas interference issues.

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.

A new high-grade discovery deep beneath a century-old mine could revive a legendary BC mining district and bolster Canada's critical mineral supply.